Novo Nordisk and Roche Diabetes Care launch new treatment option

3 November 2014

Danish diabetes care giant Novo Nordisk (NOV: N) has launched NovoRapid PumpCart, the first pre-filled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps.

The new cartridge, which contains NovoRapid (insulin aspart), aims to make insulin pump therapy more convenient for people with diabetes. The PumpCart is being launched in the UK, Sweden and Austria today and will be made available in more European countries throughout 2015 and 2016.

It has been developed in a non-exclusive partnership between Swiss drug major Roche (ROG: SIX) and Novo Nordisk, as the cartridge is compatible with the new Accu-Chek Insight insulin pump therapy system from Roche Diabetes Care. The Accu-Chek Insight insulin pump therapy system has been launched in Austria in the first half of this year and is being launched in the UK today, with other European markets following throughout 2015.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK